http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7749162

Outgoing Links

Predicate Object
contentType Clinical Trial|Journal Article|Multicenter Study|Randomized Controlled Trial
endingPage 40
issn 0920-1211
issueIdentifier 1
pageRange 31-40
publicationName Epilepsy Research
startingPage 31
bibliographicCitation Kälviäinen R, Brodie MJ, Duncan J, Chadwick D, Edwards D, Lyby K. A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group. Epilepsy Res. 1998 Mar;30(1):31–40. doi: 10.1016/s0920-1211(97)00082-x. PMID: 9551842.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff1b94b514c3c42bd6a9a972db48fb8a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d8c687818a5a5d27afb7c11afad1d3d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da67481a1fcf8bedfdc838d829174a51
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a142f4ee06dd63b1d22180707d3e1a69
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a3b1db3596bf3f69d246ee208fbe8d15
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b8a334cdadf12ba9da9511c96c99d1f
date 199803
identifier https://pubmed.ncbi.nlm.nih.gov/9551842
https://doi.org/10.1016/s0920-1211%2897%2900082-x
isPartOf https://portal.issn.org/resource/ISSN/0920-1211
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group
discusses http://id.nlm.nih.gov/mesh/M0001382
http://id.nlm.nih.gov/mesh/M0164774
http://id.nlm.nih.gov/mesh/M0016932
http://id.nlm.nih.gov/mesh/M0014864
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D009557Q000627
http://id.nlm.nih.gov/mesh/D004828Q000188
http://id.nlm.nih.gov/mesh/D000927Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000078308
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D017029Q000188
http://id.nlm.nih.gov/mesh/D004562
http://id.nlm.nih.gov/mesh/D010919
http://id.nlm.nih.gov/mesh/D004828Q000503
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D000927Q000009
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D004569
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D009460
http://id.nlm.nih.gov/mesh/D017029Q000503
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D004359
http://id.nlm.nih.gov/mesh/D009557Q000009
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91274
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6983
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7483
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6654
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7618
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60648
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907

Total number of triples: 58.